Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness - Full Text View

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness

This study has been completed.

Sponsored by:	Innovative Medical
Information provided by:	Innovative Medical
ClinicalTrials.gov Identifier:	NCT00469521

Purpose

To determine baseline tear thickness and improvement immediately post installation of two artificial tear solutions:(9582X) and Allergan Refresh Tears.

Condition	Intervention	Phase
Tear Film Thickness	Drug: Refresh Tears, 9582X	Phase IV

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Non-Randomized, Open Label, Active Control, Parallel Assignment

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

Normal, healthy volunteers 18 years or older
Males or females
Any race or ethnic background

Exclusion Criteria:

Corneal refractive surgery within 6 months of this study.
Contact lens use on day of examination.
Corneal ectasia

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00469521

Locations

United States, South Carolina
Magill Research Center Institute MUSC
Charleston, South Carolina, United States, 29425

Sponsors and Collaborators

Innovative Medical

Investigators

Principal Investigator:

Helga Sandoval, MS, MD

Magill Research Center Institute MUSC

More Information

Study ID Numbers:	5304
Study First Received:	May 2, 2007
Last Updated:	September 5, 2007
ClinicalTrials.gov Identifier:	NCT00469521
Health Authority:	United States:Institution Review Board

Study placed in the following topic categories:

Lacerations

ClinicalTrials.gov processed this record on January 16, 2009